Smart insulin pump may boost brain and body health in older adults with diabetes

NCT ID NCT06236256

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests whether an advanced hybrid closed loop insulin pump (MiniMed 780G) can improve blood sugar control, quality of life, thinking skills, and physical abilities in people over 60 with type 1 diabetes. Participants are randomly assigned to either continue their usual insulin therapy or use the automated system for 12 months. The goal is to see if this technology offers extra benefits beyond standard care for older adults.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
MiniMed 780G advanced hybrid closed loop insulin pump system
What this could lead to
If successful, this could show that automated insulin delivery improves not only blood sugar control but also physical function, thinking skills, and quality of life in older adults with type 1 diabetes.
What could go wrong
This is a small, early-stage trial with only 42 participants, so results may not apply to everyone. The device requires consistent use and may not work equally well for all individuals.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 1 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Sheba medical center

    Ramat Gan, Israel, 52621, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.